Healthcare automation startup Syllable raised $40 million in a Series C funding round to boost patient experience with intelligent voice solutions for health system call centers and healthcare offices.
Funding was led by growth equity firm TCV with participation from existing investors Oak HC/FT, Section32, and Verily. The fresh capital will be used by Syllable to further develop its central product, the Syllable Patient Assistant.
See also: Connected Healthcare Speaks up as Investments Pour Into Voice AI
“Syllable’s automation has demonstrated our ability to modernize the healthcare contact center and improve the patient experience. We work closely with health systems to provide intelligent, automated features with the Syllable Patient Assistant, and focus on improving access to care for all patients in the U.S.” Kobus Jooste, CEO of Syllable, said in a press release on Thursday (April 28).
The Syllable Patient Assistant connects with patients on the phone, online, or by text messaging. Syllable aims to link patients with the pertinent information they’re looking for as well as the appropriate practitioners needed for care.
Related: To Fix Patient Payments, Include Consumers in the Consumerization of Healthcare
Syllable uses machine learning (ML) and natural language understanding (NLU) to give patients an improved experience while also lowering operational overhead and workforce stress for healthcare systems.
More health systems across the country have been tapping Syllable as medical offices and hospital departments get busy again with everyday inquiries and calls for appointments as the COVID pandemic fades. An increasing number of facilities and practitioners are also turning to Syllable due to the rise in patients’ expectations for better access, convenience and personalization when it comes to getting care.
Read more: Payments Is the Prescription for Healthier Patient, Provider Cash Flow
“Implementing truly patient-centric call center automation and digital self-service tools are critical steps for health systems to better serve their patients. Syllable’s technology platform and approach are poised to do just that,” TCV General Partner Matt Brennan said.
Headquartered in Silicon Valley and co-founded in 2017 by CEO Kobus Jooste and Andrew Rogers, Syllable is striving to transform the way health systems provide access to care. It works with many of the biggest healthcare providers in the U.S.